 | • レポートコード：D0GIR-01759 • 出版社/出版日：GlobalInfoResearch / 2020年9月23日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、104ページ • 納品方法：Eメール • 産業分類：医療、製薬、バイオ |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、サルコペニア治療薬の世界市場を広く調査・分析し、今後の市場展望をまとめております。サルコペニア治療薬の種類別市場規模（プロテインサプリ、カルシウムサプリ、その他）、用途別市場規模（オンライン薬局、小売薬局）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Abbott Laboratories、GlaxoSmithKline、Amway、Nestlé、A&Z Pharmaceutical、Pfizer、H&H、Usana、By-health、Bayer、Blackmores、Zhendong Group ・地域別グローバル市場分析 2015年-2020年 ・サルコペニア治療薬の北米市場（アメリカ、カナダ、メキシコ） ・サルコペニア治療薬のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・サルコペニア治療薬のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・サルコペニア治療薬の南米市場（ブラジル、アルゼンチン） ・サルコペニア治療薬の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：プロテインサプリ、カルシウムサプリ、その他 ・用途別分析：オンライン薬局、小売薬局 ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論 |
Market Overview
The Sarcopenia Therapeutic market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
The most likely (base case) scenario is that the global Sarcopenia Therapeutic sales will be xx in 2020 from Sarcopenia Therapeutic million in 2019, with a change xx% between 2019 and 2020. In addition, based on the latest study, it is to predict that the Covid-19 will be under control in key countries like the United States, Western Europe, East Asia, by the end of Q2 (June), and will resume normal production in Q3 and Q4, the global Sarcopenia Therapeutic market size is expected to grow at xx% or more annually for the next five years.
This report also researches and evaluates the impact of Covid-19 outbreak on the Sarcopenia Therapeutic industry, involving potential opportunity and challenges, drivers and risks. We present the impact assessment of Covid-19 effects on Sarcopenia Therapeutic and market growth forecast based on different scenario (optimistic, pessimistic, very optimistic, most likely etc.).
Market segmentation
Sarcopenia Therapeutic market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Sarcopenia Therapeutic market has been segmented into:
Protein Supplement
Calcium Supplement
Other
By Application, Sarcopenia Therapeutic has been segmented into:
Online Pharmacies
Retail Pharmacies
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Sarcopenia Therapeutic market presented in the report. This section sheds light on the sales growth of different regional and country-level Sarcopenia Therapeutic markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Sarcopenia Therapeutic market.
The report offers in-depth assessment of the growth and other aspects of the Sarcopenia Therapeutic market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Sarcopenia Therapeutic Market Share Analysis
Sarcopenia Therapeutic competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Sarcopenia Therapeutic sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Sarcopenia Therapeutic sales, revenue and market share for each player covered in this report.
The major players covered in Sarcopenia Therapeutic are:
Abbott Laboratories
GlaxoSmithKline
Amway
Nestlé
A&Z Pharmaceutical
Pfizer
H&H
Usana
By-health
Bayer
Blackmores
Zhendong Group
Among other players domestic and global, Sarcopenia Therapeutic market share data is available for global, North America, Europe, Asia-Pacific, Middle East & Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
1 Sarcopenia Therapeutic Market Overview
1.1 Product Overview and Scope of Sarcopenia Therapeutic
1.2 Classification of Sarcopenia Therapeutic by Type
1.2.1 Global Sarcopenia Therapeutic Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Sarcopenia Therapeutic Revenue Market Share by Type in 2019
1.2.3 Protein Supplement
1.2.4 Calcium Supplement
1.2.5 Other
1.3 Global Sarcopenia Therapeutic Market by Application
1.3.1 Overview: Global Sarcopenia Therapeutic Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Online Pharmacies
1.3.3 Retail Pharmacies
1.4 Global Sarcopenia Therapeutic Market by Regions
1.4.1 Global Sarcopenia Therapeutic Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Sarcopenia Therapeutic (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Sarcopenia Therapeutic Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Sarcopenia Therapeutic Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Sarcopenia Therapeutic Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Sarcopenia Therapeutic Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Sarcopenia Therapeutic Status and Prospect (2015-2025)
1.5 COVID-19 Outbreak: Sarcopenia Therapeutic Industry Impact
1.5.1 COVID-19 Potential Implications for the Sarcopenia Therapeutic
1.5.1.1 Scenario One: Very Optimistic: COVID-19 has No Influence on Sarcopenia Therapeutic
1.5.1.2 Scenario Two: Optimistic: COVID-19 Will Be Under Control by the End of April
1.5.1.3 Scenario Three: Gloomy: COVID-19 Will Be Under Control Between Q3 and Q4
1.5.1.4 Scenario Four: Most Likely: COVID-19 Will Be Under Control by the End of Q2
1.5.2 Opportunity Analysis in Covid-19 Crisis
1.5.3 Market Risk and Restraints
1.5.4 Market Driving Force
2 Company Profiles
2.1 Abbott Laboratories
2.1.1 Abbott Laboratories Details
2.1.2 Abbott Laboratories Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Abbott Laboratories SWOT Analysis
2.1.4 Abbott Laboratories Product and Services
2.1.5 Abbott Laboratories Sarcopenia Therapeutic Revenue, Gross Margin and Market Share (2018-2019)
2.2 GlaxoSmithKline
2.2.1 GlaxoSmithKline Details
2.2.2 GlaxoSmithKline Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 GlaxoSmithKline SWOT Analysis
2.2.4 GlaxoSmithKline Product and Services
2.2.5 GlaxoSmithKline Sarcopenia Therapeutic Revenue, Gross Margin and Market Share (2018-2019)
2.3 Amway
2.3.1 Amway Details
2.3.2 Amway Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Amway SWOT Analysis
2.3.4 Amway Product and Services
2.3.5 Amway Sarcopenia Therapeutic Revenue, Gross Margin and Market Share (2018-2019)
2.4 Nestlé
2.4.1 Nestlé Details
2.4.2 Nestlé Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Nestlé SWOT Analysis
2.4.4 Nestlé Product and Services
2.4.5 Nestlé Sarcopenia Therapeutic Revenue, Gross Margin and Market Share (2018-2019)
2.5 A&Z Pharmaceutical
2.5.1 A&Z Pharmaceutical Details
2.5.2 A&Z Pharmaceutical Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 A&Z Pharmaceutical SWOT Analysis
2.5.4 A&Z Pharmaceutical Product and Services
2.5.5 A&Z Pharmaceutical Sarcopenia Therapeutic Revenue, Gross Margin and Market Share (2018-2019)
2.6 Pfizer
2.6.1 Pfizer Details
2.6.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Pfizer SWOT Analysis
2.6.4 Pfizer Product and Services
2.6.5 Pfizer Sarcopenia Therapeutic Revenue, Gross Margin and Market Share (2018-2019)
2.7 H&H
2.7.1 H&H Details
2.7.2 H&H Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 H&H SWOT Analysis
2.7.4 H&H Product and Services
2.7.5 H&H Sarcopenia Therapeutic Revenue, Gross Margin and Market Share (2018-2019)
2.8 Usana
2.8.1 Usana Details
2.8.2 Usana Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Usana SWOT Analysis
2.8.4 Usana Product and Services
2.8.5 Usana Sarcopenia Therapeutic Revenue, Gross Margin and Market Share (2018-2019)
2.9 By-health
2.9.1 By-health Details
2.9.2 By-health Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 By-health SWOT Analysis
2.9.4 By-health Product and Services
2.9.5 By-health Sarcopenia Therapeutic Revenue, Gross Margin and Market Share (2018-2019)
2.10 Bayer
2.10.1 Bayer Details
2.10.2 Bayer Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Bayer SWOT Analysis
2.10.4 Bayer Product and Services
2.10.5 Bayer Sarcopenia Therapeutic Revenue, Gross Margin and Market Share (2018-2019)
2.11 Blackmores
2.11.1 Blackmores Details
2.11.2 Blackmores Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Blackmores SWOT Analysis
2.11.4 Blackmores Product and Services
2.11.5 Blackmores Sarcopenia Therapeutic Revenue, Gross Margin and Market Share (2018-2019)
2.12 Zhendong Group
2.12.1 Zhendong Group Details
2.12.2 Zhendong Group Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Zhendong Group SWOT Analysis
2.12.4 Zhendong Group Product and Services
2.12.5 Zhendong Group Sarcopenia Therapeutic Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Sarcopenia Therapeutic Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Sarcopenia Therapeutic Players Market Share
3.2.2 Top 10 Sarcopenia Therapeutic Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Sarcopenia Therapeutic Revenue and Market Share by Regions
4.2 North America Sarcopenia Therapeutic Revenue and Growth Rate (2015-2020)
4.3 Europe Sarcopenia Therapeutic Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Sarcopenia Therapeutic Revenue and Growth Rate (2015-2020)
4.5 South America Sarcopenia Therapeutic Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Sarcopenia Therapeutic Revenue and Growth Rate (2015-2020)
5 North America Sarcopenia Therapeutic Revenue by Countries
5.1 North America Sarcopenia Therapeutic Revenue by Countries (2015-2020)
5.2 USA Sarcopenia Therapeutic Revenue and Growth Rate (2015-2020)
5.3 Canada Sarcopenia Therapeutic Revenue and Growth Rate (2015-2020)
5.4 Mexico Sarcopenia Therapeutic Revenue and Growth Rate (2015-2020)
6 Europe Sarcopenia Therapeutic Revenue by Countries
6.1 Europe Sarcopenia Therapeutic Revenue by Countries (2015-2020)
6.2 Germany Sarcopenia Therapeutic Revenue and Growth Rate (2015-2020)
6.3 UK Sarcopenia Therapeutic Revenue and Growth Rate (2015-2020)
6.4 France Sarcopenia Therapeutic Revenue and Growth Rate (2015-2020)
6.5 Russia Sarcopenia Therapeutic Revenue and Growth Rate (2015-2020)
6.6 Italy Sarcopenia Therapeutic Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Sarcopenia Therapeutic Revenue by Countries
7.1 Asia-Pacific Sarcopenia Therapeutic Revenue by Countries (2015-2020)
7.2 China Sarcopenia Therapeutic Revenue and Growth Rate (2015-2020)
7.3 Japan Sarcopenia Therapeutic Revenue and Growth Rate (2015-2020)
7.4 Korea Sarcopenia Therapeutic Revenue and Growth Rate (2015-2020)
7.5 India Sarcopenia Therapeutic Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Sarcopenia Therapeutic Revenue and Growth Rate (2015-2020)
8 South America Sarcopenia Therapeutic Revenue by Countries
8.1 South America Sarcopenia Therapeutic Revenue by Countries (2015-2020)
8.2 Brazil Sarcopenia Therapeutic Revenue and Growth Rate (2015-2020)
8.3 Argentina Sarcopenia Therapeutic Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Sarcopenia Therapeutic by Countries
9.1 Middle East & Africa Sarcopenia Therapeutic Revenue by Countries (2015-2020)
9.2 Saudi Arabia Sarcopenia Therapeutic Revenue and Growth Rate (2015-2020)
9.3 UAE Sarcopenia Therapeutic Revenue and Growth Rate (2015-2020)
9.4 Egypt Sarcopenia Therapeutic Revenue and Growth Rate (2015-2020)
9.5 South Africa Sarcopenia Therapeutic Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Sarcopenia Therapeutic Revenue and Market Share by Type (2015-2020)
10.2 Global Sarcopenia Therapeutic Market Forecast by Type (2019-2024)
10.3 Protein Supplement Revenue Growth Rate (2015-2025)
10.4 Calcium Supplement Revenue Growth Rate (2015-2025)
10.5 Other Revenue Growth Rate (2015-2025)
11 Global Sarcopenia Therapeutic Market Segment by Application
11.1 Global Sarcopenia Therapeutic Revenue Market Share by Application (2015-2020)
11.2 Sarcopenia Therapeutic Market Forecast by Application (2019-2024)
11.3 Online Pharmacies Revenue Growth (2015-2020)
11.4 Retail Pharmacies Revenue Growth (2015-2020)
12 Global Sarcopenia Therapeutic Market Size Forecast (2021-2025)
12.1 Global Sarcopenia Therapeutic Market Size Forecast (2021-2025)
12.2 Global Sarcopenia Therapeutic Market Forecast by Regions (2021-2025)
12.3 North America Sarcopenia Therapeutic Revenue Market Forecast (2021-2025)
12.4 Europe Sarcopenia Therapeutic Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Sarcopenia Therapeutic Revenue Market Forecast (2021-2025)
12.6 South America Sarcopenia Therapeutic Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Sarcopenia Therapeutic Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Sarcopenia Therapeutic Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Sarcopenia Therapeutic by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Sarcopenia Therapeutic Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Sarcopenia Therapeutic Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Global Sarcopenia Therapeutic Market Size and Growth Estimation in Various Scenarios in 2020
Table 6. Abbott Laboratories Corporate Information, Location and Competitors
Table 7. Abbott Laboratories Sarcopenia Therapeutic Major Business
Table 8. Abbott Laboratories Sarcopenia Therapeutic Total Revenue (USD Million) (2017-2018)
Table 9. Abbott Laboratories SWOT Analysis
Table 10. Abbott Laboratories Sarcopenia Therapeutic Product and Solutions
Table 11. Abbott Laboratories Sarcopenia Therapeutic Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 12. GlaxoSmithKline Corporate Information, Location and Competitors
Table 13. GlaxoSmithKline Sarcopenia Therapeutic Major Business
Table 14. GlaxoSmithKline Sarcopenia Therapeutic Total Revenue (USD Million) (2018-2019)
Table 15. GlaxoSmithKline SWOT Analysis
Table 16. GlaxoSmithKline Sarcopenia Therapeutic Product and Solutions
Table 17. GlaxoSmithKline Sarcopenia Therapeutic Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 18. Amway Corporate Information, Location and Competitors
Table 19. Amway Sarcopenia Therapeutic Major Business
Table 20. Amway Sarcopenia Therapeutic Total Revenue (USD Million) (2017-2018)
Table 21. Amway SWOT Analysis
Table 22. Amway Sarcopenia Therapeutic Product and Solutions
Table 23. Amway Sarcopenia Therapeutic Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 24. Nestlé Corporate Information, Location and Competitors
Table 25. Nestlé Sarcopenia Therapeutic Major Business
Table 26. Nestlé Sarcopenia Therapeutic Total Revenue (USD Million) (2017-2018)
Table 27. Nestlé SWOT Analysis
Table 28. Nestlé Sarcopenia Therapeutic Product and Solutions
Table 29. Nestlé Sarcopenia Therapeutic Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 30. A&Z Pharmaceutical Corporate Information, Location and Competitors
Table 31. A&Z Pharmaceutical Sarcopenia Therapeutic Major Business
Table 32. A&Z Pharmaceutical Sarcopenia Therapeutic Total Revenue (USD Million) (2017-2018)
Table 33. A&Z Pharmaceutical SWOT Analysis
Table 34. A&Z Pharmaceutical Sarcopenia Therapeutic Product and Solutions
Table 35. A&Z Pharmaceutical Sarcopenia Therapeutic Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 36. Pfizer Corporate Information, Location and Competitors
Table 37. Pfizer Sarcopenia Therapeutic Major Business
Table 38. Pfizer Sarcopenia Therapeutic Total Revenue (USD Million) (2017-2018)
Table 39. Pfizer SWOT Analysis
Table 40. Pfizer Sarcopenia Therapeutic Product and Solutions
Table 41. Pfizer Sarcopenia Therapeutic Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 42. H&H Corporate Information, Location and Competitors
Table 43. H&H Sarcopenia Therapeutic Major Business
Table 44. H&H Sarcopenia Therapeutic Total Revenue (USD Million) (2017-2018)
Table 45. H&H SWOT Analysis
Table 46. H&H Sarcopenia Therapeutic Product and Solutions
Table 47. H&H Sarcopenia Therapeutic Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 48. Usana Corporate Information, Location and Competitors
Table 49. Usana Sarcopenia Therapeutic Major Business
Table 50. Usana Sarcopenia Therapeutic Total Revenue (USD Million) (2017-2018)
Table 51. Usana SWOT Analysis
Table 52. Usana Sarcopenia Therapeutic Product and Solutions
Table 53. Usana Sarcopenia Therapeutic Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 54. By-health Corporate Information, Location and Competitors
Table 55. By-health Sarcopenia Therapeutic Major Business
Table 56. By-health Sarcopenia Therapeutic Total Revenue (USD Million) (2017-2018)
Table 57. By-health SWOT Analysis
Table 58. By-health Sarcopenia Therapeutic Product and Solutions
Table 59. By-health Sarcopenia Therapeutic Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 60. Bayer Corporate Information, Location and Competitors
Table 61. Bayer Sarcopenia Therapeutic Major Business
Table 62. Bayer Sarcopenia Therapeutic Total Revenue (USD Million) (2017-2018)
Table 63. Bayer SWOT Analysis
Table 64. Bayer Sarcopenia Therapeutic Product and Solutions
Table 65. Bayer Sarcopenia Therapeutic Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 66. Blackmores Corporate Information, Location and Competitors
Table 67. Blackmores Sarcopenia Therapeutic Major Business
Table 68. Blackmores Sarcopenia Therapeutic Total Revenue (USD Million) (2017-2018)
Table 69. Blackmores SWOT Analysis
Table 70. Blackmores Sarcopenia Therapeutic Product and Solutions
Table 71. Blackmores Sarcopenia Therapeutic Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 72. Zhendong Group Corporate Information, Location and Competitors
Table 73. Zhendong Group Sarcopenia Therapeutic Major Business
Table 74. Zhendong Group Sarcopenia Therapeutic Total Revenue (USD Million) (2017-2018)
Table 75. Zhendong Group SWOT Analysis
Table 76. Zhendong Group Sarcopenia Therapeutic Product and Solutions
Table 77. Zhendong Group Sarcopenia Therapeutic Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 78. Global Sarcopenia Therapeutic Revenue (Million USD) by Players (2015-2020)
Table 79. Global Sarcopenia Therapeutic Revenue Share by Players (2015-2020)
Table 80. Global Sarcopenia Therapeutic Revenue (Million USD) by Regions (2015-2020)
Table 81. Global Sarcopenia Therapeutic Revenue Market Share by Regions (2015-2020)
Table 82. North America Sarcopenia Therapeutic Revenue by Countries (2015-2020)
Table 83. North America Sarcopenia Therapeutic Revenue Market Share by Countries (2015-2020)
Table 84. Europe Sarcopenia Therapeutic Revenue (Million USD) by Countries (2015-2020)
Table 85. Asia-Pacific Sarcopenia Therapeutic Revenue (Million USD) by Countries (2015-2020)
Table 86. South America Sarcopenia Therapeutic Revenue by Countries (2015-2020)
Table 87. South America Sarcopenia Therapeutic Revenue Market Share by Countries (2015-2020)
Table 88. Middle East and Africa Sarcopenia Therapeutic Revenue (Million USD) by Countries (2015-2020)
Table 89. Middle East and Africa Sarcopenia Therapeutic Revenue Market Share by Countries (2015-2020)
Table 90. Global Sarcopenia Therapeutic Revenue (Million USD) by Type (2015-2020)
Table 91. Global Sarcopenia Therapeutic Revenue Share by Type (2015-2020)
Table 92. Global Sarcopenia Therapeutic Revenue Forecast by Type (2021-2025)
Table 93. Global Sarcopenia Therapeutic Revenue by Application (2015-2020)
Table 94. Global Sarcopenia Therapeutic Revenue Share by Application (2015-2020)
Table 95. Global Sarcopenia Therapeutic Revenue Forecast by Application (2021-2025)
Table 96. Global Sarcopenia Therapeutic Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Sarcopenia Therapeutic Picture
Figure 2. Global Sarcopenia Therapeutic Revenue Market Share by Type in 2019
Figure 3. Protein Supplement Picture
Figure 4. Calcium Supplement Picture
Figure 5. Other Picture
Figure 6. Sarcopenia Therapeutic Revenue Market Share by Application in 2019
Figure 7. Online Pharmacies Picture
Figure 8. Retail Pharmacies Picture
Figure 9. Global Sarcopenia Therapeutic Revenue (USD Million) and Growth Rate (2015-2025)
Figure 10. North America Sarcopenia Therapeutic Revenue (Million USD) and Growth Rate (2015-2025)
Figure 11. Europe Sarcopenia Therapeutic Revenue (Million USD) and Growth Rate (2015-2025)
Figure 12. Asia-Pacific Sarcopenia Therapeutic Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. South America Sarcopenia Therapeutic Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Middle East and Africa Sarcopenia Therapeutic Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Global Sarcopenia Therapeutic Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Global Sarcopenia Therapeutic Revenue Share by Players in 2019
Figure 17. Global Top 5 Players Sarcopenia Therapeutic Revenue Market Share in 2019
Figure 18. Global Top 10 Players Sarcopenia Therapeutic Revenue Market Share in 2019
Figure 19. Key Players Market Share Trend
Figure 20. Global Sarcopenia Therapeutic Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 21. Global Sarcopenia Therapeutic Revenue Market Share by Regions (2015-2020)
Figure 22. Global Sarcopenia Therapeutic Revenue Market Share by Regions in 2018
Figure 23. North America Sarcopenia Therapeutic Revenue and Growth Rate (2015-2020)
Figure 24. Europe Sarcopenia Therapeutic Revenue and Growth Rate (2015-2020)
Figure 25. Asia-Pacific Sarcopenia Therapeutic Revenue and Growth Rate (2015-2020)
Figure 26. South America Sarcopenia Therapeutic Revenue and Growth Rate (2015-2020)
Figure 27. Middle East and Africa Sarcopenia Therapeutic Revenue and Growth Rate (2015-2020)
Figure 28. North America Sarcopenia Therapeutic Revenue Market Share by Countries (2015-2020)
Figure 29. North America Sarcopenia Therapeutic Revenue Market Share by Countries in 2019
Figure 30. USA Sarcopenia Therapeutic Revenue and Growth Rate (2015-2020)
Figure 31. Canada Sarcopenia Therapeutic Revenue and Growth Rate (2015-2020)
Figure 32. Mexico Sarcopenia Therapeutic Revenue and Growth Rate (2015-2020)
Figure 33. Europe Sarcopenia Therapeutic Revenue Market Share by Countries (2015-2020)
Figure 34. Europe Sarcopenia Therapeutic Revenue Market Share by Countries in 2019
Figure 35. Germany Sarcopenia Therapeutic Revenue and Growth Rate (2015-2020)
Figure 36. UK Sarcopenia Therapeutic Revenue and Growth Rate (2015-2020)
Figure 37. France Sarcopenia Therapeutic Revenue and Growth Rate (2015-2020)
Figure 38. Russia Sarcopenia Therapeutic Revenue and Growth Rate (2015-2020)
Figure 39. Italy Sarcopenia Therapeutic Revenue and Growth Rate (2015-2020)
Figure 40. Asia-Pacific Sarcopenia Therapeutic Revenue Market Share by Countries (2015-2020)
Figure 41. Asia-Pacific Sarcopenia Therapeutic Revenue Market Share by Countries in 2019
Figure 42. China Sarcopenia Therapeutic Revenue and Growth Rate (2015-2020)
Figure 43. Japan Sarcopenia Therapeutic Revenue and Growth Rate (2015-2020)
Figure 44. Korea Sarcopenia Therapeutic Revenue and Growth Rate (2015-2020)
Figure 45. India Sarcopenia Therapeutic Revenue and Growth Rate (2015-2020)
Figure 46. Southeast Asia Sarcopenia Therapeutic Revenue and Growth Rate (2015-2020)
Figure 47. South America Sarcopenia Therapeutic Revenue Market Share by Countries (2015-2020)
Figure 48. South America Sarcopenia Therapeutic Revenue Market Share by Countries in 2019
Figure 49. Brazil Sarcopenia Therapeutic Revenue and Growth Rate (2015-2020)
Figure 50. Argentina Sarcopenia Therapeutic Revenue and Growth Rate (2015-2020)
Figure 51. Middle East and Africa Sarcopenia Therapeutic Revenue Market Share by Countries (2015-2020)
Figure 52. Middle East and Africa Sarcopenia Therapeutic Revenue Market Share by Countries in 2019
Figure 53. Saudi Arabia Sarcopenia Therapeutic Revenue and Growth Rate (2015-2020)
Figure 54. UAE Sarcopenia Therapeutic Revenue and Growth Rate (2015-2020)
Figure 55. Egypt Sarcopenia Therapeutic Revenue and Growth Rate (2015-2020)
Figure 56. South Africa Sarcopenia Therapeutic Revenue and Growth Rate (2015-2020)
Figure 57. Global Sarcopenia Therapeutic Revenue Share by Type (2015-2020)
Figure 58. Global Sarcopenia Therapeutic Revenue Share by Type in 2019
Figure 59. Global Sarcopenia Therapeutic Market Share Forecast by Type (2021-2025)
Figure 60. Global Protein Supplement Revenue Growth Rate (2015-2020)
Figure 61. Global Calcium Supplement Revenue Growth Rate (2015-2020)
Figure 62. Global Other Revenue Growth Rate (2015-2020)
Figure 63. Global Sarcopenia Therapeutic Revenue Share by Application (2015-2020)
Figure 64. Global Sarcopenia Therapeutic Revenue Share by Application in 2019
Figure 65. Global Sarcopenia Therapeutic Market Share Forecast by Application (2021-2025)
Figure 66. Global Online Pharmacies Revenue Growth Rate (2015-2020)
Figure 67. Global Retail Pharmacies Revenue Growth Rate (2015-2020)
Figure 68. Global Sarcopenia Therapeutic Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 69. Global Sarcopenia Therapeutic Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 70. Global Sarcopenia Therapeutic Revenue Market Share Forecast by Regions (2021-2025)
Figure 71. North America Sarcopenia Therapeutic Revenue Market Forecast (2021-2025)
Figure 72. Europe Sarcopenia Therapeutic Revenue Market Forecast (2021-2025)
Figure 73. Asia-Pacific Sarcopenia Therapeutic Revenue Market Forecast (2021-2025)
Figure 74. South America Sarcopenia Therapeutic Revenue Market Forecast (2021-2025)
Figure 75. Middle East and Africa Sarcopenia Therapeutic Revenue Market Forecast (2021-2025)
Figure 76. Sales Channel: Direct Channel vs Indirect Channel
サルコペニアサプリメントの世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The Sarcopenia Supplement market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization,…- 脊髄性筋萎縮症（SMA）治療の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The Spinal Muscular Atrophy (SMA) Therapeutic market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value…
- 外分泌膵不全治療薬の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The Exocrine Pancreatic Insufficiency Therapeutic market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, v…
- TDP治療装置の世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The TDP Therapeutic Apparatus market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimizat…
- 抗菌治療の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Antibacterial Therapeutic market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 3.1% in the forecast period of 2020 to 2025 and will expected to reach USD 124550 million by 2025, from USD 110400 million in 2019. The Antibacter…